A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression.

Source:http://linkedlifedata.com/resource/pubmed/id/21163924

Blood 2011 Feb 24 117 8 2396-404

Download in:

View as

General Info

PMID
21163924